NYSE · PHARMACEUTICAL PREPARATIONS · LARGE CAP
Novo Nordisk A/S NVO
7 fiscal years on record · DKK · FY2025 reported
SEC FILINGS ONLY3 YEARS OF DIVIDEND GROWTH
Revenue · FY2025
DKK 309.1B
▲ 6.4% vs FY2024
Dividend streak
3 yrs
Raised every year since 2023
EPS · FY25
DKK 23.03
Dividend / sh · FY25
DKK 11.70
Payout · FY25
51%
ROE · FY25
—
Net margin · FY25
33.1%
Dividend coverage
2.0×
Advertisement
AdSense · Leaderboard 728×90320×100
Result
DKK 309.1B
Revenue, FY2025 · full 7-year series below
Revenue
Net income
33 cents of every revenue dollar became profit this year.
Per share
DKK 23.03
Diluted EPS, FY2025
EPS
Dividend
Earnings covered the dividend 2.0 times — the rest stayed in the company.
Profitability
—
Return on equity, FY2025
ROE
Operating margin41.3%
Net margin33.1%
Return on assets20.3%
Returned to shareholders
DKK 53.2B
returned in FY2025 · dividends + net buybacks
Dividends paidDKK 51.8B
Net buybacksDKK 1.4B
Share of profit51.9%
Consecutive raises3 years
DKK 51.8B in dividends and DKK 1.4B in buybacks — 52% of the year's profit went back to shareholders.
Growth
+19.5% a year
revenue, compounded over five years
CAGR
3 yrs
5 yrs
10 yrs
15 yrs
Revenue
+20.4%
+19.5%
Net income
+22.6%
+19.4%
EPS, diluted
+23.5%
Dividend / share
+23.6%
Returned to shareholders
+2.5%
+7.5%
Compound annual rates per period — left blank where the series crosses a loss.
Share base
4.44B
Shares outstanding, FY2025
Change, 5 years—
Change, 10 years—
A share split breaks the comparison across the period, so we leave it out.
Advertisement
AdSense · Leaderboard 728×90300×250
Balance sheet
DKK 542.9B
total assets, end of FY2025
Total assetsDKK 542.9B
CashDKK 26.5B
Gross debtDKK 131.0B
Net debtDKK 104.5B
Current ratio0.80×
History
7 fiscal years
Every figure from documents filed with the SEC · DKK
Metric
2025
2024
2023
2022
2021
2020
2019
Revenue DKK B
309.1
290.4
232.3
177.0
140.8
126.9
122.0
Operating income DKK B
127.7
128.3
102.6
74.8
58.6
54.1
52.5
EBITDA DKK B
142.3
136.9
109.9
81.4
64.7
59.9
58.1
Income tax DKK B
28.1
26.2
21.0
13.5
11.3
11.0
9.6
Net income DKK B
102.4
101.0
83.7
55.5
47.8
42.1
39.0
EPS, diluted DKK
23.03
22.63
18.62
12.22
10.37
18.01
16.38
Dividend / sh DKK
11.70
11.40
9.40
6.20
10.40
9.10
·
Payout %
51
44
38
46
45
48
50
ROE %
·
·
·
·
·
·
·
Shares out B
4.44
4.44
4.46
4.50
4.62
2.35
2.40
Slide the table for earlier years · "·" marks figures not disclosed in the filing for that year.
How we verifyAUDITED
26 of 26
checks passed before publication
EPS recomputationBalance-sheet identityGross profitBalance-sheet liquidity
Every figure was compared against the original statement: 0 failures and 0 presentation gaps.
What we don’t show
We’d rather say what’s missing than fill the gap with an estimate.
P/E rationeeds a market quote — not yet licensed
Market capitalizationneeds a market quote — not yet licensed
Dividend yieldneeds a market quote — not yet licensed
Price-to-bookneeds a market quote — not yet licensed